MetLife Investment Management’s Carisma Therapeutics CARM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-14,186	Closed	-$60K	–	2833
2023 Q3	$60K	Hold	14,186	–	–	﹤0.01%	2803
2023 Q2	$124K	Buy	+14,186	New	+$124K	﹤0.01%	2552
2021 Q3	–	Sell	-3,273	Closed	-$302K	–	2571
2021 Q2	$302K	Buy	+3,273	New	+$302K	﹤0.01%	1884